Even as snow socked Washington, the Food and Drug Administration managed to get a letter to GlaxoSmithKline rejecting the company's proposal to sell the pill Avodart as a way to reduce the risk of prostate cancer.
Originally published on Mon November 19, 2012 11:03 am
This year, NPR had its largest ever "boots on the ground" presence at the International Consumer Electronics Show – the industry's largest confab of technology and innovation. So, why is CES – a sea of mass prototype electronics and gadgetry – so important to a public radio organization? And equally important, why did our small but fierce Digital Media and NPR Labs teams bravely navigate their way through miles of cluttered conference space and the crowd of more than 140,000 attendees?
Some primitive stone hand-axes and scrapers unearthed in a desert on the eastern side of the Arabian Peninsula suggest that the first modern humans may have left Africa earlier and by a different route than scientists had previously thought.
Jonathan Cohn is a senior editor at The New Republic and a senior fellow at Demos.
Did Obama say enough about health care reform last night? I suppose I'm one of the very few people who would even ask that question. Most Americans would probably think, "More health care? Lord no." And I think Obama and his speechwriters sensed as much. Although his defense of the Affordable Care Act was clear — he's not going to sign a bill repealing the law — it was also short. That portion of the speech was just two brief paragraphs, by my count.
The Pentagon is on the verge of a budget crisis and the blame lies with the Congress, Defense Secretary Robert Gates told reporters during an interview Wednesday.
The U.S. defense budget is being funded through a continuing resolution that authorizes spending at 2010 levels, or about $526 billion. That's $23 billion less than the $549 billion the Obama administration asked for in its budget proposal 11 months ago.